Who is UHP
About UHP
Our mission...
... at United Healthcare Partners (UHP) is to make sure that innovative treatments for rare and orphan diseases make it to their end target - the patient.
For more than 14 years, we have been offering
tailor-made, patient-centered services according
to the highest safety- and quality standards.
This makes us a trusted one-stop solution-provider for patients, support groups, health insurances, biotechnology and pharmaceutical companies alike.
![People Elements-24 [Converted]-UHP.png](https://static.wixstatic.com/media/397cd0_cc5f8be26a504e84b0c305aa72fa0673~mv2.png/v1/fill/w_835,h_383,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/People%20Elements-24%20%5BConverted%5D-UHP.png)
We help make your medicine a success story
>28 countries
Our footprint reaches across EMEA
>100,000
Drug Deliveries per year
GDP- & GMP-certified
Pre-Wholesale & Wholesale Services
>600
Highly qualified nurses
Our Value Drivers
Homecare & Nursing
At UHP, we put the patient first.
With our network of more than 600 qualified nurses in Europe, we provide specialized medical homecare services, in close coordination with the treating physician, for more than 5.000 patients each year. All our nurses are experienced in the treatment of rare disease patients and receive individual training based on the project-specific indication and treatment details. Our flexible face-to-face homecare services adjust to the patient’s personal and professional schedule. This allows us to optimize the patient support for a higher chance of a positive therapy outcome.
42,000+
infusions per year
5,000
patients on therapy
across Europe
15,000+
self-application trainings
each year
34,560
hours of QM training
courses in 2020
Our therapy areas
-
Short bowel syndrome (SBS)
-
Hemophilia
-
hATTR-Amyloidosis
-
Pulmonary Arterial Hypertension (PAH)
-
Alpha-mannosidosis
-
Myasthenia Gravis
UHP has 14+ years of experience in numerous rare disease indications.
These therapy areas include:
​
-
Morbus Fabry
-
Morbus Gaucher
-
Morbus Pompe
-
MPS I, II, IV & VI
-
Hereditary angioedema (HAE)
-
Acid Sphingomyelinase Deficiency
Reporting & Management
The seasoned Data Science & Project Management experts at UHP can provide you with a range of tailor-made services to help facilitate your lifecycle management from the clinical study phase over the support in Early Access Programs to Patient Support Programs and even beyond the commercial roll-out in the European market.
With numerous successful project launches in the past 10 years, we are a trusted partner for pharmaceutical & Life Science companies.
Supply Chain & Logistics
Entering the European market as a Life Science company comes with a range of demanding challenges.
With a footprint in more than 28 countries, we are ready to help you overcome them with our experience in Logistics, Customs Warehousing, and Supply Chain-Management according to GDP-standards. We facilitate the market access of your pharmaceutical products with our in-depth knowledge of the market- and country-specific regulations. With our GMP-certification, we are also prepared to import,
re-package and distribute your product to all European markets.
CONTACT US
United Healthcare Partners
Blegistrasse 11b
6341, Baar
Switzerland
​
+49 (0) 2161 6398271
Connect with us on LinkedIn